Assessment of the risk of positive surgical margins with pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: a prospective study

By Soulie M.   Aziza R.   Escourrou G.   Seguin P.   Tollon C.   Molinier L.   Bachaud J.-M.   Joffre F.   Plante P.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 228-232

Elsevier

Access to resources Recommend Favorite

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer

By Yoon J.H.   Chen M.-H.   Renshaw A.A.   Richie J.P.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 454-457

Elsevier

Access to resources Recommend Favorite

RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy

By Gewanter R.M.   Katz A.E.   Olsson C.A.   Benson M.C.   Singh A.   Schiff P.B.   Ennis R.D.  

Urology, Vol. 61, Iss. 5, 2003-05 ,pp. : 967-971

Elsevier

Access to resources Recommend Favorite

An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy

By D'amico A.V.   Whittington R.   Malkowicz S.B.   Loughlin K.   Schultz D.   Schnall M.   Tempany C.M.   Tomaszewski J.E.   Renshaw A.   Wein A.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 538-547

Elsevier

Access to resources Recommend Favorite

Distinguishing prognostic and treatment-predictive information for localized prostate cancer

By Steineck G.   Adolfsson J.   Scher H.I.   Whitmore W.F.  

Urology, Vol. 45, Iss. 4, 1995-04 ,pp. : 610-615

Elsevier

Access to resources Recommend Favorite